Navigation Links
BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update
Date:7/30/2009

BIRMINGHAM, Ala., July 30 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced financial results for the quarter and six months ended June 30, 2009 and provided a corporate update regarding clinical programs and potential emergency use of intravenous (i.v.) peramivir in the U.S.

"Our efforts at BioCryst remain focused on moving our leading peramivir and forodesine clinical development programs forward," said Jon P. Stonehouse, President and Chief Executive Officer of BioCryst Pharmaceuticals. "BioCryst continues to work diligently with government agencies to provide i.v. peramivir as a potential treatment option for an influenza emergency, as well as working to complete the U.S. development of peramivir through the traditional regulatory pathway. The successful Phase 3 studies conducted by our partner Shionogi add to the growing body of data characterizing the efficacy and safety of peramivir as a potential treatment for influenza."

Second Quarter Financial Results

For the three months ended June 30, 2009, collaborative and other research and development revenues were $4.8 million compared to $2.7 million for the three months ended June 30, 2008. Revenues related to the Company's contract with the U.S. Department of Health and Human Services (HHS) for the development of peramivir were higher in this year's quarter compared to the prior year period due to a $4.9 million reserve recorded against revenue in 2008 for amounts BioCryst had previously expected to receive from HHS. The increase in peramivir related revenues was offset by a reduction in revenue from the Company's collaborations with Mundipharma, as well as lower amortization of deferred revenue from our collaboration arrangements.

Research and development (R&D) expenses
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. BioCryst Pharmaceuticals Announces Presentation of Forodesine Data at the 45th Annual Meeting of the American Society of Clinical Oncology
2. BioCryst to Present at the 11th Annual BIO CEO & Investor Conference
3. BioCryst Pharmaceuticals to Announce Fourth Quarter and Year End 2008 Financial Results on February 6, 2009
4. BioCryst to Present at the Rodman and Renshaw 10th Annual Healthcare Conference
5. BioCryst Reports Positive Results From a Phase 2 Study of Intravenous Peramivir for Outpatient Influenza
6. BioCryst Pharmaceuticals to Announce First Quarter 2008 Financial Results on May 8, 2008
7. BioCryst to Release Third Quarter 2007 Financial Results on Thursday, November 8, 2007
8. Encision Reports Profitable First Fiscal Quarter Results
9. Nutraceutical Reports Fiscal 2009 Q3 Results and Expands Share Repurchase Program
10. Tyco International Reports Third Quarter Earnings from Continuing Operations Before Special Items of $0.58 Per Share and GAAP Earnings of $0.51 Per Share
11. BioMed Realty Trust Reports Second Quarter 2009 Operating and Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... At the annual National League ... San Antonio, esteemed experts and thought leaders will ... in the way of successful organizational performance: resistance, ... faculty development opportunity is made possible through the ... to assist nurse educators to advance to leadership ...
(Date:12/21/2014)... In this report, the global powered ... product, and application. The market, by power source, ... By product, the market covers the handpieces; power ... market is further subdivided into drills, saws, reamers, ... shavers, wire/pin drivers, and others. Moreover, the power ...
(Date:12/21/2014)... Weddingshe.com, an outstanding online supplier of wedding dresses ... new selection of Cocktail Dresses for the winter 2014. ... newest fashion trends. , “We take pride ... . All of them are offered at greatly discounted ... every effort to offer a nice shopping experience for ...
(Date:12/21/2014)... (PRWEB) December 21, 2014 Khanna Vision ... a guest at the Aspen Helicopters holiday event for ... a Santa with sleigh, flown by an aspen helicopter ... invisible; only Santa with sleigh was visible.(please see accompanying ... and night. Dr.Khanna has helped many pilots with Pi ...
(Date:12/21/2014)... (PRWEB) December 21, 2014 AngelWeddingDress.com’s new ... There is a total of 1,000 new designs in ... the coming spring 2015. , AngelWeddingDress.com promises ... female shoppers with wardrobe essentials while many fashion trends ... problems, the customer service team at AngelWeddingDress.com is ready ...
Breaking Medicine News(10 mins):Health News:2015 NLN Leadership Conference February 5-7 San Antonio 2Health News:2015 NLN Leadership Conference February 5-7 San Antonio 3Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 3Health News:Global Powered Surgical Instruments Market Hit to $2.1 billion by 2019 - New Research Report by MarketsandMarkets 4Health News:Stunning Cocktail Party Dresses from Weddingshe.com 2Health News:2015 Spring Wedding Dresses From AngelWeddingDress Just Released 2
... results across MDS, TORONTO, Sept. 6 /PRNewswire-FirstCall/ ... providing products and services to the global life ... For the quarter,MDS reported revenues of $321 million, ... from continuing operations of $0.07. Adjusted EBITDA,rose to ...
... product a proven treatment -, BELLEVILLE, ON, ... BNC), a research-based, technology-driven Canadian,biopharmaceutical company, today announced ... Australia in order to be able to respond ... continent,s equine influenza outbreak.,The outbreak began in August, ...
... N.Y., Sept. 6 /PRNewswire/, Who: Breast Cancer patients, survivors and ... (a breast cancer support center) on Thursday, September 6, What: ... ... wheels to encourage them to Keep ... to give cancer patients, survivors and caregivers a much needed ...
... Fairbank Farms, a national,ground beef producer, is ... Beef Patties. The ground beef patties, sold fresh,under ... consumers in New,England on Wednesday September 5, 2007 ... of caution, the product has been removed from ...
... Va., Sept. 5 AMERIGROUP,Corporation (NYSE: AGP ) ... Corporation have approved the sale of its assets,including TLC ... subject to regulatory approval by the State of Tennessee. ... of 2007. TLC Family Care Health Plan serves ...
... YORK, Sept. 5 Belfast Merger Co., a,wholly owned ... the expiration date for its cash tender offer for ... Inc. (Nasdaq: DADE ). The,tender offer has been ... September 26, 2007. The tender offer is being made ...
Cached Medicine News:Health News:MDS Reports Third Quarter 2007 Results 2Health News:MDS Reports Third Quarter 2007 Results 3Health News:MDS Reports Third Quarter 2007 Results 4Health News:MDS Reports Third Quarter 2007 Results 5Health News:MDS Reports Third Quarter 2007 Results 6Health News:MDS Reports Third Quarter 2007 Results 7Health News:MDS Reports Third Quarter 2007 Results 8Health News:MDS Reports Third Quarter 2007 Results 9Health News:MDS Reports Third Quarter 2007 Results 10Health News:MDS Reports Third Quarter 2007 Results 11Health News:MDS Reports Third Quarter 2007 Results 12Health News:MDS Reports Third Quarter 2007 Results 13Health News:MDS Reports Third Quarter 2007 Results 14Health News:MDS Reports Third Quarter 2007 Results 15Health News:MDS Reports Third Quarter 2007 Results 16Health News:MDS Reports Third Quarter 2007 Results 17Health News:MDS Reports Third Quarter 2007 Results 18Health News:MDS Reports Third Quarter 2007 Results 19Health News:MDS Reports Third Quarter 2007 Results 20Health News:MDS Reports Third Quarter 2007 Results 21Health News:MDS Reports Third Quarter 2007 Results 22Health News:MDS Reports Third Quarter 2007 Results 23Health News:MDS Reports Third Quarter 2007 Results 24Health News:MDS Reports Third Quarter 2007 Results 25Health News:MDS Reports Third Quarter 2007 Results 26Health News:MDS Reports Third Quarter 2007 Results 27Health News:MDS Reports Third Quarter 2007 Results 28Health News:MDS Reports Third Quarter 2007 Results 29Health News:MDS Reports Third Quarter 2007 Results 30Health News:MDS Reports Third Quarter 2007 Results 31Health News:MDS Reports Third Quarter 2007 Results 32Health News:MDS Reports Third Quarter 2007 Results 33Health News:Bioniche Responds to Australian Equine Influenza Outbreak 2Health News:Bioniche Responds to Australian Equine Influenza Outbreak 3Health News:New York City Cancer Patients, Survivors and Care Givers Encouraged to Keep Going(R) 2
(Date:12/17/2014)... Revenue and earnings above the previous year - ... In the past 2013/14 fiscal year (ended 30 September ... 4.287 billion (last year: EUR 4.190 billion) despite unfavorable currency ... million. "Overall, 2013/14 was a successful fiscal year for the ... CEO of Carl Zeiss AG. "Thanks to our broad portfolio ...
(Date:12/17/2014)... Ariz. , Dec. 17, 2014  Beamz ... state-of-the-art interactive music products, today announced that it ... a leading manufacturer and supplier of innovative prosthetic, ... As part of the agreement, RSL Steeper ... bundled solution specifically configured for use within UK ...
(Date:12/17/2014)... Dec. 17, 2014  RXi Pharmaceuticals Corporation (NASDAQ: ... on discovering, developing and commercializing innovative therapies addressing ... completion of enrollment in its first Phase 2a ... observations confirmed the 1-month findings that were reported ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO , ...
Breaking Medicine Technology:ZEISS Asserts its Position in Difficult Environment 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5
Icefire has ice crystals on the top of a cool blue iris....
This pattern transform your pupils into narrow slits surrounded by eye stopping yellow. Works well with kitty-cat costumes....
Silicone tip cannula angled at 7 mm, sterile, disposable (bx/10)....
Maumenee vitreous aspirating cannula, 18 gauge....
Medicine Products: